Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Intent to Sole Source: Research Services for Advanced…

U.S. Department Of Veterans Affairs·Georgia

Intent to Sole Source: Research Services for Advanced Bladder Cancer

Closes 7/24/2026$500k – $2MSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Veterans Affairs, Network Contracting Office 07 (NCO 07), intends to award a sole source contract for Research Services of Advanced Bladder Cancer to the University of Alabama at Birmingham Department of Urology. The contract is expected to be awarded under the authority of 41 U.S.C. 3304(a)(1), as implemented by RFO 12.102(a) - Restricting competition. The contractor will provide research services for advanced bladder cancer for one base year and three option years. The services will be performed at the Birmingham VA Medical Center. • The contract is for a firm fixed price. • The contractor must provide research services for advanced bladder cancer. • The services will be performed at the Birmingham VA Medical Center. • The contract is expected to be awarded under the authority of 41 U.S.C. 3304(a)(1). • The contractor must be registered in the System for Award Management (SAM) to be eligible for award.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Ashley N Stewart(Contract Specialist)

[email protected]

Key dates

Opened
7/21/2026
Closes
7/24/2026
Projected award
7/27/2026
Duration
4 years

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
541720

Budget estimate

$500,000 – $2,000,000

The budget for this contract is not explicitly stated in the document. However, based on the NAICS code 541720, which is for Research and Development in the Social Sciences and Humanities, and the fact that the contract is for research services for advanced bladder cancer, the budget could be in the range of $500,000 to $2 million. This estimate is based on the assumption that the research services will require a team of researchers and support staff, and the cost of their salaries, equipment, and other expenses. The actual budget could be higher or lower, depending on the specific requirements of the contract and the qualifications of the contractor.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

University of South Carolina·South Carolina

Top match · 72%

Notice Of Intent To Sole Source – University of South Carolina Collaborative ALS Research Services

Rolling / TBD closeOpened 10/5/2026

University of South Carolina·South Carolina

70% match

Notice of Intent to Sole Source – University of South Carolina – Social Monitor Services

Rolling / TBD closeOpened 7/21/2026

Department of Public Health·South Carolina

69% match

Notice Of Intent To Sole Source By: Department of Public Health

Rolling / TBD closeOpened 10/1/2026

U.S. Food and Drug Administration·United States of America

68% match

Novel approaches to support therapeutic development in ultra-rare cancers

Rolling / TBD closeOpened 8/4/2025

Clemson University·South Carolina

68% match

Pharmaceutical and Biomedical Research

Closes 2/28/2029Opened 6/5/2024

State University of New York (SUNY)·New York

68% match

Bladder Scanners and Related Products

Closes 11/23/2026Opened 10/30/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

68% match

Health Promotion and Disease Prevention Research Centers: 2027 Special Interest Project Supplements (SIPS)

Closes 4/21/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

68% match

Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)

Closes 1/8/2027Opened 5/14/2025

U.S. National Institutes of Health·United States of America

68% match

Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)

Closes 1/24/2027Opened 7/16/2026

U.S. Office to Monitor-Combat Trafficking in Persons·United States of America

68% match

Notice of Intent: Program to End Modern Slavery FY 2023

Rolling / TBD closeOpened 1/20/2023

U.S. National Institutes of Health·United States of America

68% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

Department of Public Health·South Carolina

68% match

Notice of Intent to Sole Source – South Carolina Department of Public Health

Rolling / TBD closeOpened 8/10/2026

U.S. National Institutes of Health·United States of America

68% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

67% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

67% match

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

Closes 11/9/2026Opened 9/3/2025

U.S. National Institutes of Health·United States of America

67% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

67% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. Department Of Health And Human Services·Maryland

67% match

Intent to Sole Source - Procurement of BD Mission™ Disposable Core Biopsy Instrument (semi-automatic, single-use)

Closes 11/8/2026Opened 10/29/2026

U.S. National Institutes of Health·United States of America

67% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

State University of New York (SUNY)·New York

67% match

Medovent Oncology data specialists support services

Closes 11/17/2026Opened 10/26/2026

U.S. Department Of Health And Human Services·Maryland

67% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

67% match

Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)

Closes 11/17/2026Opened 9/18/2025

Washington Suburban Sanitary Commission·Maryland

67% match

Request for Information WSSC Water Biosolids Market Research

Closes 11/30/2026Opened 10/29/2026

U.S. National Institutes of Health·United States of America

67% match

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

67% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026